Longitudinal risk of herpes zoster in patients with non-Hodgkin lymphoma receiving chemotherapy: A nationwide population-based study

This study investigated the incidence of and risk factors for herpes zoster in patients with non-Hodgkin lymphoma (NHL) who were receiving anti-lymphoma treatment. The overall incidence density of herpes zoster was 12.21% (472/3865); 11.79% (258/2188) of the patients received conventional chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Shih-Feng, Wu, Wan-Hsuan, Yang, Yi-Hsin, Liu, Yi-Chang, Hsiao, Hui-Hua, Chang, Chao-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585724/
https://www.ncbi.nlm.nih.gov/pubmed/26391893
http://dx.doi.org/10.1038/srep14008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585724/
https://www.ncbi.nlm.nih.gov/pubmed/26391893
http://dx.doi.org/10.1038/srep14008

Ejemplares similares